SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $54,799 | -50.0% | 14,160 | -22.9% | 0.00% | – |
Q2 2023 | $109,515 | -55.9% | 18,375 | -75.8% | 0.00% | – |
Q1 2023 | $248,151 | +41.8% | 75,887 | +71.3% | 0.00% | – |
Q4 2022 | $175,000 | -33.5% | 44,292 | +1.0% | 0.00% | – |
Q3 2022 | $263,000 | -7.7% | 43,833 | -0.9% | 0.00% | – |
Q2 2022 | $285,000 | -17.9% | 44,224 | +5.3% | 0.00% | – |
Q1 2022 | $347,000 | -39.7% | 42,011 | +13.1% | 0.00% | – |
Q4 2021 | $575,000 | -34.0% | 37,140 | -4.0% | 0.00% | – |
Q3 2021 | $871,000 | +25.5% | 38,685 | +9.6% | 0.00% | – |
Q2 2021 | $694,000 | -91.2% | 35,291 | -85.0% | 0.00% | -100.0% |
Q1 2021 | $7,900,000 | – | 236,059 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |